QUANTUM GENOM NR Share Price Euronext Paris
Equities
FR0010783837
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 7.49M 8.08M 634M |
---|---|---|---|---|---|
Net income 2024 * | -3M -3.24M -254M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 8.7M 9.39M 736M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.19
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.23% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | - | |
Lionel Ségard
FOU | Founder | 56 | 22/12/05 |
Benoît Gueugnon
DFI | Director of Finance/CFO | - | 30/06/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lionel Ségard
FOU | Founder | 56 | 22/12/05 |
François Pelen
BRD | Director/Board Member | 67 | - |
Chief Executive Officer | 63 | - |
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.44B | |
-10.62% | 37.68B | |
+40.49% | 39.84B | |
+29.92% | 31.46B | |
-9.78% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |